SCHEMBL24318099

SCHEMBL24318099

CCc1c[nH]c([C@H](Cc2ccc(NS(=O)(=O)O)cc2)NC(=O)CCc2ccc(OC)cc2)n1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770301 0.91 PTPRB (0.73) PTPRB
SCHEMBL24767257 0.90 PTPRB (0.69) PTPRB
SCHEMBL24318259 0.83 PTPRB (0.68) PTPRB
SCHEMBL500433 0.83 PTPRB (1.00) PTPRB
SCHEMBL500434 0.83 PTPRB (1.00) PTPRB
SCHEMBL24767306 0.79 PTPRB (0.52) PTPRB
SCHEMBL24319135 0.78 PTPRB (0.56) PTPRB
SCHEMBL24767156 0.77 PTPRB (0.51) PTPRB
SCHEMBL23770170 0.76 PTPRB (0.74) PTPRB
SCHEMBL24767253 0.76 PTPRB (0.54) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101297-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Pharmaceuticals, Inc. (US) 2022-12-14 EP disclosed
EP-3977994-A1 ACTIVATORS OF TIE-2 FOR USE IN TREATING INTRAOCULAR PRESSURE Aerpio Pharmaceuticals, Inc. (US) 2022-04-06 EP disclosed